Overweight is associated with improved survival and outcomes in patients with atrial fibrillation

Clinical Research in Cardiology

Volumn 103, Issue 7, 2014, Pages 533-542

  Wang, Juan ^a   Yang, Yan Min ^a   Zhu, Jun ^a   Zhang, Han ^a   Shao, Xing Hui ^a   Tian, Li ^a   Huang, Bi ^a   Yu, Li Tian ^a   Gao, Xin ^a   Wang, Man ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Atrial fibrillation; Body mass index; Combined end events; Mortality; Obesity; Overweight

Indexed keywords

AGED; ARTICLE; BLEEDING; BODY MASS; CARDIOVASCULAR MORTALITY; CHINA; CHINESE; CLINICAL TRIAL; COMORBIDITY; EMBOLISM; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; SURVIVAL RATE; UNDERWEIGHT; ATRIAL FIBRILLATION; BODY WEIGHT; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OVERWEIGHT; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BODY MASS INDEX; CHINA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IDEAL BODY WEIGHT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THINNESS;

EID: 84902831165     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0681-7     Document Type: Article

References (32)

1. Berrington De Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee I, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ (2010) Body-mass index and mortality among 1.46 Million white adults. New Engl J Med 363:2211-2219
2. Wilson PW, D"Agostino RB, Sullivan L, Parise H, Kannel WB (2002) Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med 162:1867-1872
3. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F (2006) Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368:666-678 (Pubitemid 44223694)
4. Mehta RH, Califf RM, Garg J, White HD, Van de Werf F, Armstrong PW, Pieper KS, Topol EJ, Granger CB (2007) The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction. Eur Heart J 28:415-424 (Pubitemid 47343554)
5. Angerås O, Albertsson P, Karason K, Råmunddal T, Matejka G, James S, Lagerqvist B, Rosengren A, Omerovic E (2013) Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J 34:345-353
6. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M (2007) An obesity paradox in acute heart failure. Analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153:74-81 (Pubitemid 44880872)
7. Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO (2013) Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Failure 1:93-102
8. Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper- Dehoff RM, Zhou Q, Pepine CJ (2007) Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 120:863-870 (Pubitemid 47451305)
9. Galal W, van Gestel YR, Hoeks SE, Sin DD, Winkel TA, Bax JJ, Verhagen H, Awara AM, Klein J, van Domburg RT, Poldermans D (2008) The obesity paradox in patients with peripheral arterial disease. Chest 134:925-930
10. Doehner W, Schenkel J, Anker SD, Springer J, Audebert HJ (2013) Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: Observations from the TEMPiS trial. Eur Heart J 34:268-277
11. Guenette JA, Jensen D, O'Donnell DE (2010) Respiratory function and the obesity paradox. Curr Opin Clin Nutr Metab Care 13:618-624
12. Singanayagam A, Singanayagam A, Chalmers JD (2013) Obesity is associated with improved survival in community-acquired pneumonia. Eur Respir J 42:180-187
13. Beddhu S (2004) The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease. Semin Dial 17:229-232
14. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Vardas P, Al-Attar N, Alfieri O, Angelini A, Blomstrom-Lundqvist C, Colonna P, De Sutter J, Ernst S, Goette A, Gorenek B, Hatala R, Heidbuchel H, Heldal M, Kristensen SD, Kolh P, Le Heuzey JY, Mavrakis H, Mont L, Filardi PP, Ponikowski P, Prendergast B, Rutten FH, Schotten U, Van Gelder IC, Verheugt FW (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719-2747
15. Ardestani A, Hoffman HJ, Cooper HA (2010) Obesity and outcomes among patients with established atrial fibrillation. Am J Cardiol 106:369-373
16. Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, Afonso L, Jacob S (2010) Influence of obesity on outcomes in atrial fibrillation: Yet another obesity paradox. Am J Med 123:646-651
17. Overvad TF, Rasmussen LH, Skjoth F, Overvad K, Lip GY, Larsen TB (2013) Body mass index and adverse events in patients with incident atrial fibrillation. Am J Med 126:640-649
18. Cheng TO (2004) Chinese body mass index is much lower as a risk factor for coronary artery disease. Circulation 109:e184
19. Zhou BF (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults - study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15:83-96
20. Wang TJ, Parise H, Levy D, D"Agostino RS, Wolf PA, Vasan RS, Benjamin EJ (2004) Obesity and the risk of new-onset atrial fibrillation. JAMA 292:2471-2477 (Pubitemid 39552671)
21. Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE, Buring JE, Albert CM (2010) The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women"s health study). J Am Coll Cardiol 55:2319-2327
22. Guglin M, Maradia K, Chen R, Curtis AB (2011) Relation of obesity to recurrence rate and burden of atrial fibrillation. Am J Cardiol 107:579-582
23. Tsang TS, Barnes ME, Miyasaka Y, Cha SS, Bailey KR, Verzosa GC, Seward JB, Gersh BJ (2008) Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J 29:2227-2233
24. Tang RB, Liu XH, Kalifa J, Li ZA, Dong JZ, Yang Y, Liu XP, Long DY, Yu RH, Ma CS (2009) Body mass index and risk of left atrial thrombus in patients with atrial fibrillation. Am J Cardiol 104:1699-1703
25. Nieuwlaat R, Prins MH, Le Heuzey JY, Vardas PE, Aliot E, Santini M, Cobbe SM, Widdershoven JW, Baur LH, Levy S, Crijns HJ (2008) Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J 29:1181-1189 (Pubitemid 351844895)
26. Issac TT, Dokainish H, Lakkis NM (2007) Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 50:2021-2028 (Pubitemid 350087568)
27. Richter B, Gwechenberger M, Socas A, Zorn G, Albinni S, Marx M, Bergler-Klein J, Binder T, Wojta J, Gossinger HD (2012) Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol 101:217-225
28. Rossi A, Enriquez-Sarano M, Burnett JJ, Lerman A, Abel MD, Seward JB (2000) Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 35:1256-1262
29. Rienstra M, Van Gelder IC, Van den Berg MP, Boomsma F, Van Veldhuisen DJ (2006) Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: Determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Europace 8:482-487 (Pubitemid 43985484)
30. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109:594-600 (Pubitemid 38198866)
31. Greif M, von Ziegler F, Wakili R, Tittus J, Becker C, Helbig S, Laubender RP, Schwarz W, D'Anastasi M, Schenzle J, Leber AW, Becker A (2013) Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation. Clin Res Cardiol 102:555-562
32. Coutinho T, Goel K, Correa DSD, Carter RE, Hodge DO, Kragelund C, Kanaya AM, Zeller M, Park JS, Kober L, Torp-Pedersen C, Cottin Y, Lorgis L, Lee SH, Kim YJ, Thomas R, Roger VL, Somers VK, Lopez-Jimenez F (2013) Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol 61:553-560